Skip to main content
. 2024 Oct 15;14(10):4803–4816. doi: 10.62347/MWLI5585

Table 2.

Comparison of imaging characteristics

Parameter No adverse reactions (n=113) Adverse reactions (n=47) t/χ2 P
Tumor Lobe (Y/N) 51 (45.13%)/62 (54.87%) 23 (48.94%)/24 (51.06%) 0.07 0.791
Bronchial Invasion (Y/N) 35 (30.97%)/78 (69.03%) 16 (34.04%)/31 (65.96%) 0.037 0.847
Pleural Effusion (Y/N) 15 (13.27%)/98 (86.73%) 5 (10.64%)/42 (89.36%) 0.039 0.844
Spiculation (Y/N) 42 (37.17%)/71 (62.83%) 16 (34.04%)/31 (65.96%) 0.038 0.846